US5441986A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Estrogen agonists as remedies for prostate and cardiovascular diseases
Assignee: Pfizer Inc
•
Filing: 1994-07-19
•
Granted: 1995-08-15
•
Expires: 2014-07-19
Abstract
Abstract Use of droloxifene in the treatment of benign prostatic hyperplasia, prostatic carcinoma and cardiovascular diseases.
Inventors
- 👤 David D. Thompson
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 05:50
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/13; A61K31/135; A61K31/138; A61P; A61P13/00; A61P13/02; A61P15/00; A61P3/00; A61P3/04; A61P3/06; A61P35/00; A61P9/00; A61P9/10
Claims Analysis
Total Claims: 3
Claim 1
Independent Claim
30 words
A method of treating benign prostatic hyperplasia which comprises administering to a mammal suffering from benign prostatic hyperplasia a therapeutically effective amount of droloxifene or a pharmaceutically acceptable salt thereof.
Claim 2
Independent Claim
30 words
A method of treating benign prostatic hyperplasia which comprises administering to a mammal suffering from benign prostatic hyperplasia a therapeutically effective amount of droloxifene or a pharmaceutically acceptable salt thereof.
Claim 3
Dependent Claim
14 words
A method of claim 1 wherein said pharmaceutically acceptable salt is the citrate salt.
References Cited (Backward Citations)
US5047431A
Cited
US5254594A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1998-08-14 | 1999-02-13 | 1999-08-15 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2002-08-14 | 2003-02-13 | 2003-08-15 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2006-08-14 | 2007-02-13 | 2007-08-15 | $7700.00 | Window Closed / Lapsed |